KalVista Pharmaceuticals, Inc. short interest in 2026
In 2026, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 39.25% of shares outstanding on 15 Jan 2026 to 13.36% on 29 May 2026, a change of -25.89 percentage points. The year's high was 39.75% on 31 Mar 2026 and its low 13.36% on 29 May 2026, averaging 33.94% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.75 days on 27 Feb 2026. Full history: KalVista Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 39.25% (15 Jan 2026)
- End of year
- 13.36% (29 May 2026)
- Change
- -25.89 pp
- High
- 39.75% (31 Mar 2026)
- Low
- 13.36% (29 May 2026)
- Average
- 33.94%
- Highest days to cover
- 38.75 (27 Feb 2026)
- SEC filings marked
- 3
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 39.25% | 11.16 | results (8-K) |
| 30 Jan 2026 | 39.71% | 25.44 | |
| 13 Feb 2026 | 39.18% | 28.78 | |
| 27 Feb 2026 | 38.16% | 38.75 | |
| 13 Mar 2026 | 38.46% | 17.65 | |
| 31 Mar 2026 | 39.75% | 15.92 | results (8-K) |
| 15 Apr 2026 | 38.35% | 20.74 | |
| 30 Apr 2026 | 29.60% | 1.83 | |
| 15 May 2026 | 23.53% | 3.07 | 10-Q filed |
| 29 May 2026 | 13.36% | 1.97 |
See also: KalVista Pharmaceuticals, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.